Perissi V, Menini N, Cottone E, Capello D, Sacco M, Montaldo F, De Bortoli M
Institute for Cancer Research and Treatment (IRCC), Str. Prov. 142, Km. 3.95, 10060 Candiolo, Italy.
Oncogene. 2000 Jan 13;19(2):280-8. doi: 10.1038/sj.onc.1203303.
Transcription of the ERBB2 oncogene is repressed by oestrogen in human breast cancer cells. We show that a 218 bp fragment of the human ERBB2 gene promoter is responsive to oestrogen in transient transfection in ZR75.1 and SKBR.3 cells when the oestrogen receptor is expressed. Deletion analysis of this fragment shows that a sequence located at the 5' end, which is known to mediate ERBB2 overexpression in breast cancer, is also responsible for the oestrogen response. This sequence binds AP-2 transcription factors and appears functionally identical to an element of the oestrogen-dependent enhancer described in the first intron of human ERBB2. We observed that oestrogen treatment down-regulates expression of AP-2 proteins but does not affect the DNA binding activity of AP-2. Constitutive expression of AP-2beta or AP-2gamma, but not AP-2alpha, abrogates the estrogenic repression. Our results demonstrate that AP-2 transcription factors are implicated in the oestrogenic regulation of ERBB2 gene expression and suggest a complex interplay involving the different AP-2 isoforms and other unidentified factors.
在人乳腺癌细胞中,雌激素可抑制ERBB2癌基因的转录。我们发现,当雌激素受体表达时,人ERBB2基因启动子的一个218 bp片段在ZR75.1和SKBR.3细胞的瞬时转染中对雌激素有反应。对该片段的缺失分析表明,位于5'端的一个序列(已知其介导乳腺癌中ERBB2的过表达)也负责雌激素反应。该序列结合AP-2转录因子,并且在功能上似乎与人ERBB2第一内含子中描述的雌激素依赖性增强子元件相同。我们观察到,雌激素处理可下调AP-2蛋白的表达,但不影响AP-2的DNA结合活性。AP-2β或AP-2γ的组成型表达(而非AP-2α)可消除雌激素抑制作用。我们的结果表明,AP-2转录因子参与了ERBB2基因表达的雌激素调节,并提示了涉及不同AP-2异构体和其他未知因子的复杂相互作用。